Dr. Jorge Maciel is a molecular microbiologist with 20+ years of research experience working in the areas of infectious diseases, immunology and protein engineering. Dr. Maciel currently supports the U.S. Army Combat Capabilities Development Command (CCDC) Chemical Biological Center (CBC) in developing new strategies against various biological and chemical agents of interest, using his knowledge of biological threat agents and the scientific principles which limit the effectiveness of current biological detectors, samples, and assays to develop new countermeasures.
Dr. Maciel joined Excet, Inc. after completion of a National Research Council (NRC) Post-Doctoral Research Fellowship with the BioDefense Branch, and was the recipient of a 2008 U.S. Army Seedling Initiative Program. In addition to his laboratory experience working with various biological agents, Dr. Maciel successfully developed a novel portable ricin activity detection substrate/assay and was competitively awarded, and served as Principal Investigator for, a multi-year Defense Threat Reduction Agency (DTRA) program to utilize new molecular display technologies to identify and create novel thermostable ligands and countermeasures to biological agents of interest in conjunction with the Defense Advanced Research Projects Agency (DARPA). In addition, Dr. Maciel has extensive experience in the evaluation of next-generation sequencing technologies and use of resulting data sets for statistical identification and characterization of microorganisms from various sample matrices, and synthetic biology. Dr. Maciel additionally conducts canine assessments, evaluations and support to olfactory research science for the Defense Department’s Military Working Dog Program.
Dr. Maciel currently serves as both a Senior Research Scientist and as the Lead Supervisor for Excet, Inc. research scientists and support staff at CCDC CBC. Dr. Maciel is a guest lecturer for multiple universities and government agencies in lecture topics ranging from biological/chemical forensics, attribution, CRISPR gene editing (e.g. https://www.youtube.com/watch?v=Yy3f2zBQbCw&t=657s) and molecular methods applicable to biological and chemical detection and characterization technologies. He received his B.S. from the University of Notre Dame (South Bend, IN) and was awarded his Ph.D. in Molecular Microbiology and Immunology from Johns Hopkins University Bloomberg School of Public Health (Baltimore, MD) and received Executive Development training from the Wharton School of Business (Philadelphia, PA).